Risk factors for readmission in schizophrenia patients following involuntary admission

PloS One
Yu-Yuan HungYi-Ju Pan

Abstract

Individuals with schizophrenia who are involuntarily admitted may have poorer prognosis, including higher readmission rates, than those voluntarily admitted. However, little is known about the risk factors for readmission in those schizophrenia patients who are involuntarily admitted. We aim to explore the risk factors for readmission in this population. We enrolled 138 schizophrenia patients with involuntary admission from July 2008 to June 2013 and followed those patients for readmission outcomes at 3 months and at 1 year. The one-year and 3-months readmission rates were 33.3% and 15.2%, respectively. Unmarried status (adjusted odds ratio (aOR) = 6.28, 95% CI: 1.48-26.62), previous history of involuntary admission (aOR = 4.08, 95% CI: 1.19-14.02), longer involuntary admission days (aOR = 1.04, 95% CI: 1.01-1.07) and shorter total admission days (aOR = 1.03, 95% CI: 1.01-1.05) were associated with increased risk for 1-year readmission. Younger age (aOR = 1.10, 95% CI 1.02-1.18) was associated with increased risk for 3-months readmission. Unmarried status, prior history of involuntary admission, longer involuntary admission days and shorter total admission days were associated with increased risk for 1-year readmission. Healthc...Continue Reading

References

Dec 1, 1992·Community Mental Health Journal·B J Cuffel
Feb 1, 1991·Psychological Medicine·A RiecherB Fätkenheuer
Jul 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·H Häfner, W an der Heiden
Jan 1, 1989·Comprehensive Psychiatry·J P McEvoyS Freter
Dec 1, 1994·The British Journal of Psychiatry : the Journal of Mental Science·P E BebbingtonJ K Wing
Jan 1, 1993·The American Journal of Psychiatry·L ApplebyD R Hedeker
Feb 4, 1998·Social Psychiatry and Psychiatric Epidemiology·S P SinghG Harrison
Aug 13, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·S FennigS Fennig
Jul 9, 2002·Acta Psychiatrica Scandinavica·Martin Zinkler, Stefan Priebe
Mar 29, 2003·Psychiatric Services : a Journal of the American Psychiatric Association·Patricia ThiedaJohn Kane
Jan 16, 2004·Psychological Reports·Sarah Feigon, J Ray Hays
Feb 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Hans Joachim Salize, Harald Dressing
Jan 27, 2005·Social Psychiatry and Psychiatric Epidemiology·Harald Dressing, Hans Joachim Salize
Jan 27, 2005·Social Psychiatry and Psychiatric Epidemiology·Audrey CougnardHélène Verdoux
Sep 14, 2006·Acta Psychiatrica Scandinavica·C Katsakou, S Priebe
Nov 7, 2006·Journal of Geriatric Psychiatry and Neurology·Benjamin K P WooDaniel D Sewell
Aug 23, 2007·Social Psychiatry and Psychiatric Epidemiology·Avi ValevskiRoni Shiloh
Dec 15, 2007·European Archives of Psychiatry and Clinical Neuroscience·Thomas W KallertMatthias Schützwohl
Jun 27, 2008·Psychological Medicine·A PretiUNKNOWN PROGES-Acute group
Jan 2, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Stefan PriebeKsenija Yeeles
Jun 3, 2009·Psychiatric Services : a Journal of the American Psychiatric Association·Nirma C SilvaLilian S Palazzo
Mar 3, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Stefan PriebeThomas Kallert
Mar 19, 2011·Community Mental Health Journal·John R BolaSeong-Yeon Kim
Jun 2, 2011·The International Journal of Social Psychiatry·Louk van der PostAartjan Beekman
Sep 23, 2011·Nordic Journal of Psychiatry·Lars Henrik MyklebustRolf Wynn
Jul 19, 2013·Social Psychiatry and Psychiatric Epidemiology·Louk F M van der PostJack J M Dekker

❮ Previous
Next ❯

Citations

Dec 18, 2018·Journal of Comparative Effectiveness Research·Tingjian YanAnn Hartry
Jul 2, 2019·The International Journal of Neuropsychopharmacology·Ching-Hua LinChun-Chi Hsu
Apr 6, 2019·Frontiers in Psychiatry·Barbara LayWulf Rössler
Jan 10, 2021·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Ching-Hua LinFeng-Chua Chen
Dec 12, 2020·BMC Medical Informatics and Decision Making·Matthijs BlankersJack J M Dekker
Apr 17, 2021·The International Journal of Social Psychiatry·Hua-Jian MaYang Shao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.